What is the average price target for RXSIGHT INC (RXST) stock?
16 analysts have analysed RXST and the average price target is 10.26 USD. This implies a price increase of 41.57% is expected in the next year compared to the current price of 7.25.
NASDAQ:RXST • US78349D1072
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RXSIGHT INC (RXST).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-09 | Stifel | Maintains | Hold -> Hold |
| 2026-02-26 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-26 | Needham | Reiterate | Buy -> Buy |
| 2026-02-26 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-20 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-12-02 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | Needham | Maintains | Buy -> Buy |
| 2025-11-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | Needham | Maintains | Buy -> Buy |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-07-15 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-07-10 | Jefferies | Downgrade | Buy -> Hold |
| 2025-07-09 | BTIG | Downgrade | Buy -> Neutral |
| 2025-07-09 | Needham | Reiterate | Buy -> Buy |
| 2025-07-09 | Stifel | Maintains | Hold -> Hold |
| 2025-07-09 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-07-09 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-07-09 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-19 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-04-15 | Piper Sandler | Initiate | Neutral |
| 2025-04-09 | UBS | Downgrade | Buy -> Neutral |
| 2025-04-08 | Needham | Maintains | Buy -> Buy |
| 2025-04-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 89.077M 81.75% | 139.927M 57.09% | 134.479M -3.89% | 131.77M -2.01% | 145.02M 10.06% | 156.91M 8.20% | |
| EBITDA YoY % growth | -45.842M 22.69% | -33.234M 27.50% | -44.925M -35.18% | -57.518M -28.03% | -53.683M 6.67% | -63.24M -17.80% | |
| EBIT YoY % growth | -50.085M 20.90% | -36.858M 26.41% | -48.191M -30.75% | -63.681M -32.14% | -61M 4.21% | -45.423M 25.54% | |
| Operating Margin | -56.23% | -26.34% | -35.84% | -48.33% | -42.06% | -28.95% | |
| EPS YoY % growth | -1.38 42.98% | -0.72 47.83% | -0.95 -31.94% | -1.35 -42.16% | -1.23 9.20% | -1.14 7.12% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 -43.53% | -0.35 -19.15% | -0.35 -45.41% | -0.34 -55.38% | -0.32 -13.11% | -0.33 4.65% | -0.31 10.36% | -0.30 12.07% |
| Revenue Q2Q % growth | 30.339M -19.94% | 32.855M -2.32% | 32.839M 8.24% | 35.903M 10.11% | 34.894M 15.01% | 35.88M 9.21% | 36.23M 10.33% | 38.862M 8.24% |
| EBITDA Q2Q % growth | -13.928M -40.84% | -15.963M -28.30% | -15.662M -60.42% | -16.034M -98.67% | -19.207M -37.90% | -19.798M -24.03% | -10.781M 31.16% | -14.678M 8.46% |
| EBIT Q2Q % growth | -15.079M -41.27% | -16.282M -16.27% | -16.435M -34.95% | -16.258M -43.40% | -15.579M -3.31% | -16.47M -1.15% | -13.216M 19.59% | -14.674M 9.74% |
All data in USD
16 analysts have analysed RXST and the average price target is 10.26 USD. This implies a price increase of 41.57% is expected in the next year compared to the current price of 7.25.
RXSIGHT INC (RXST) will report earnings on 2026-05-12.
The consensus EPS estimate for the next earnings of RXSIGHT INC (RXST) is -0.29 USD and the consensus revenue estimate is 30.34M USD.
The number of analysts covering RXSIGHT INC (RXST) is 16.